However, the underlying pathogenesis of MS remains unknown. One approach to identifying the mutant locus is by the 'candidate gene approach': genetic linkage studies are performed in multiplex families with candidate loci encoding components of the extracellular matrix. Several groups have already published exclusion data obtained with the major candidates, the fibrillar procollagen genes (for review see Francomano et a13). However, clinical variability between MS families is the rule and could result from defects in different connective tissue components. Therefore, it is important to confirm, in each pedigree, previously reported exclusions, for there always remains the possibility that the mutant gene may be one of the genes already excluded. Using an exceptionally large French kindred with MS, we have attempted to map the gene defect using the same approach.
Material and methods

PATIENTS
Forty-nine members of a large French pedigree (figure), comprising to date 173 subjects with at least four generations affected, were tested: three from generation II (2, 8, 10) , 20 from generation III (2, 3, 4, 5, 10, 11, 12, 13, 16, 20, 29, 33, 35, 36, 37, 40, 41, 43, 44, 52) , and 26 from generation IV (7, 8, 9, 10, 13, Table 2 Detailed results of pairzvise linkage analysis of MS and collagen gene markers. It generated a small positive lod score (Z=0 99, 0=0.00).
Discussion
Although a defect in one of the major collagen genes has long been thought to be implicated in the pathogenesis of MS, our results exclude linkage between the disease and either the type I or type II procollagen genes. Other authors have also published exclusion data between the disease and these loci.3 [18] [19] [20] In these studies, one or a few much smaller and clinically heterogeneous pedigrees were reported. Because of the great variability observed between MS families, which could be the result of heterogeneous underlying defects, our results should be compared only with data originating from phenotypically similar cases. (1) 
